Jordan was Senior Vice President of Clinical Development, Translational Science and Cardiology at Lexeo Therapeutics, and Senior Vice President of Clinical Development and Translational Science at Renovacor. Jordan Shin joined Haya Therapeutics in 2024.
Jordan Shin is currently
Create your alert
to follow the career of Jordan Shin.
Jordan Shin has a PhD in Biochemistry from University of Alabama School of Medicine.
Do you need to know more about Jordan Shin? More results.
Report an error
Update the org chart details of Jordan Shin.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.